Keywords: Atopische Dermatitis; Janus Kinase Inhibitor; Mycosis fungoides; Upadacitinib; atopic dermatitis; cutaneous T-cell lymphoma; janus kinase inhibitor; kutanes T-Zell-Lymphom; mycosis fungoides; upadacitinib.